Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
The 52 Week Low is $134.01 set on Wed, May 5, 2021.
The 52 Week High is $213.94 set on Tue, Oct 13, 2020. The current price, $166.22, is 22% below the 52 Week High.
The All-Time High is $213.94 set on Tue, Oct 13, 2020. The current price, $166.22, is 22% below the All Time High.
Seattle Genetics trades on the NASDAQ. SGEN's market cap is 30.3 Billion.
Seagen Inc. (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, Adcetris, has received approval for six indications to treat Hodgkin lymphoma and T-cell lymphoma. Other approved products include Padcev for bladder cancer and Tukysa for breast cancer. The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to several leading biotechnology and pharmaceutical companies.